Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Connective tissue graft with or without L-PRF to thicken gum tissue around delayed dental implants

Official title: Effectiveness of Connective Tissue Graft With and Without Leukocyte Platelet Rich Fibrin on Peri-implant Soft Tissue Thickness Around Delayed Implants in Patients With Thin Gingival Phenotype: A Randomized Controlled Clinical Trial

Run by British University In Egypt · NCT07368621 · Data updated 2026-11-12

This trial will test whether adding leukocyte platelet-rich fibrin (L-PRF) to a connective tissue graft helps thicken the soft tissue around delayed implants in adults with a thin gingival phenotype.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment38 (estimated)
SponsorBritish University In Egypt
Academic / other
Drugs / interventionsradiation
Locations1 site (Cairo, Cairo Governorate)
StatusRecruiting
StartedJanuary 16, 2026
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT07368621 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 years old with a thin gingival phenotype (peri-implant mucosal thickness <2 mm), a single missing tooth in the incisor/canine/premolar region, good oral hygiene, and no need for bone augmentation are ideal candidates.

Probably not a fit

Smokers, patients with systemic diseases or prior jaw radiation, those on medications that impair healing, pregnant patients, or people with poor oral hygiene are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two surgical approaches to increase buccal peri-implant mucosal thickness around delayed implants: connective tissue graft (CTG) alone versus CTG combined with leukocyte platelet-rich fibrin (L-PRF). Eligible adults with a single missing tooth in the incisor, canine, or premolar area and thin gingival phenotype (<2 mm) will receive one of the two treatments and have soft tissue thickness measured over follow-up. Patients with prior bone augmentation, smokers, or systemic conditions affecting healing are excluded. Outcomes focus on changes in mucosal thickness, peri-implant soft tissue health, and esthetic contour after implant restoration.

Why it matters

Potential benefit: If successful, the combined CTG+L-PRF approach could lead to thicker, more stable peri-implant soft tissue with improved esthetics and potentially lower risk of peri-implant bone loss.

How similar studies have gone: Connective tissue grafting is an established method to thicken peri-implant mucosa and small studies suggest L-PRF can aid soft tissue healing, but high-quality randomized data combining CTG with L-PRF remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Patients between 18-60 years. 2. With thin gingival phenotype with a peri-implant mucosal thickness of less than 2mm28. With single missing tooth in the incisor, canine and premolar area. With the presence of two natural adjacent teeth and to not have a bone augmentation procedure before or during the dental implant.

  3\. Patient consent approval and signing 4. Medically free patients 5. Patients with good oral hygiene 6. Patients free from untreated periodontal disease

Exclusion Criteria:

* 1\. Smokers 2. Psychological problem 3. Pregnancy 4. Systemic disease 5. Poor oral hygiene 6. Patients who previously received radiation therapy of the jaws 7. Patients taking medications that affect healing.

Where it's running

  • The British University in Egypt
    Cairo, Cairo Governorate, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.